Effects of Three Commonly-used Diuretics on the Urinary Proteome

Genomics, Proteomics and Bioinformatics

Volumn 12, Issue 3, 2014, Pages 120-126

  Li, Xundou ^a   Zhao, Mindi ^a   Li, Menglin ^a   Jia, Lulu ^a   Gao, Youhe ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Biomarkers; Diuretics; Urinary proteome

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN; CYSTATIN RELATED PROTEIN 2; DIURETIC AGENT; FUROSEMIDE; HAPTOGLOBIN; HYDROCHLOROTHIAZIDE; MAMMAGLOBIN A; OSTEOPONTIN; PLASMINOGEN; PROSAPOSIN; PROSTATEIN; PROTEOME; SECRETOGLOBIN; SPIRONOLACTONE; SUBMANDIBULAR GLANDULAR KALLIKREIN 9; TISSUE KALLIKREIN; TREFOIL PEPTIDE; UNCLASSIFIED DRUG; URINARY PROTEOME;

ACUTE KIDNEY FAILURE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIURETIC THERAPY; DRUG EFFECT; FEEDING; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN URINE LEVEL; PROTEOMICS; RAT; TANDEM MASS SPECTROMETRY; URINE VOLUME;

RATTUS;

BIOMARKERS; DIURETICS; URINARY PROTEOME;

ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DIURETICS; FUROSEMIDE; HUMANS; HYDROCHLOROTHIAZIDE; MALE; METABOLIC NETWORKS AND PATHWAYS; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY; SPIRONOLACTONE; TANDEM MASS SPECTROMETRY;

EID: 84903817144     PISSN: 16720229     EISSN: 22103244     Source Type: Journal    
DOI: 10.1016/j.gpb.2013.12.002     Document Type: Article

References (38)

1. Gao Y. Urine-an untapped goldmine for biomarker discovery?. Sci China Life Sci 2013, 56:1145-1146.
2. Jia L., Liu X., Liu L., Li M., Gao Y. Urimem, a membrane that can store urinary proteins simply and economically, makes the large-scale storage of clinical samples possible. Sci China Life Sci 2013, 10.1007/s11427-013-4582-1.
3. Shao C, Li M, Li X, Wei L, Zhu L, Yang F, et al. A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol Cell Proteomics 2011;10:M111.010975.
4. Rosner M.H. Urinary biomarkers for the detection of renal injury. Adv Clin Chem 2009, 49:73-97.
5. Vrooman O.P., Witjes J.A. Urinary markers in bladder cancer. Eur Urol 2008, 53:909-916.
6. Montagut C., Albanell J., Bellmunt J. Prostate cancer. Multidisciplinary approach: a key to success. Crit Rev Oncol Hematol 2008, 68:S32-36.
7. Zimmerli L.U., Schiffer E., Zürbig P., Good D.M., Kellmann M., Mouls L., et al. Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics 2008, 7:290-298.
8. Mullen W., Gonzalez J., Siwy J., Franke J., Sattar N., Mullan A., et al. A pilot study on the effect of short-term consumption of a polyphenol rich drink on biomarkers of coronary artery disease defined by urinary proteomics. J Agric Food Chem 2011, 59:12850-12857.
9. Kohler M., Franz S., Regeniter A., Ikonen A., Walpurgis K., Thomas A., et al. Comparison of the urinary protein patterns of athletes by 2D-gel electrophoresis and mass spectrometry-a pilot study. Drug Test Anal 2009, 1:382-386.
10. Kohler M., Walpurgis K., Thomas A., de Maree M., Mester J., Schänzer W., et al. Effects of endurance exercise on the urinary proteome analyzed by 2-D PAGE and Orbitrap MS. Proteomics Clin Appl 2010, 4:568-576.
11. Airoldi L., Magagnotti C., Iannuzzi A.R., Marelli C., Bagnati R., Pastorelli R., et al. Effects of cigarette smoking on the human urinary proteome. Biochem Biophys Res Commun 2009, 381:397-402.
12. Li Y., Fu C., Zhou X., Xiao Z., Zhu X., Jin M., et al. Urine interleukin-18 and cystatin-C as biomarkers of acute kidney injury in critically ill neonates. Pediatr Nephrol 2012, 27:851-860.
13. Doi K., Katagiri D., Negishi K., Hasegawa S., Hamasaki Y., Fujita T., et al. Mild elevation of urinary biomarkers in prerenal acute kidney injury. Kidney Int 2012, 82:1114-1120.
14. Jin J., Ku Y.H., Kim Y., Kim Y., Kim K., Lee J.Y., et al. Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type 2 diabetic patients. Exp Diabetes Res 2012, 2012:168602.
15. Reddy P., Mooradian A.D. Diuretics: an update on the pharmacology and clinical uses. Am J Ther 2009, 16:74-85.
16. Wisniewski J.R., Zougman A., Nagaraj N., Mann M. Universal sample preparation method for proteome analysis. Nat Methods 2009, 6:359-362.
17. Wile D. Diuretics: a review. Ann Clin Biochem 2012, 49:419-431.
18. Wang Y., Chen Y., Zhang Y., Wu S., Ma S., Hu S., et al. Differential ConA-enriched urinary proteome in rat experimental glomerular diseases. Biochem Biophys Res Commun 2008, 371:385-390.
19. Ozer J.S., Dieterle F., Troth S., Perentes E., Cordier A., Verdes P., et al. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol 2010, 28:486-494.
20. Hoffmann D., Fuchs T.C., Henzler T., Matheis K.A., Herget T., Dekant W., et al. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity. Toxicology 2010, 277:49-58.
21. Rouse R.L., Zhang J., Stewart S.R., Rosenzweig B.A., Espandiari P., Sadrieh N.K. Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int 2011, 79:1186-1197.
22. Fuchs T.C., Frick K., Emde B., Czasch S., von Landenberg F., Hewitt P. Evaluation of novel acute urinary rat kidney toxicity biomarker for subacute toxicity studies in preclinical trials. Toxicol Pathol 2012, 40:1031-1048.
23. Kentsis A., Lin Y.Y., Kurek K., Calicchio M., Wang Y.Y., Monigatti F., et al. Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry. Ann Emerg Med 2010, 55. 62-70.e4.
24. Malard V., Gaillard J.C., Berenguer F., Sage N., Quemeneur E. Urine proteomic profiling of uranium nephrotoxicity. Biochim Biophys Acta 2009, 1794:882-891.
25. Li H., Li C., Wu H., Zhang T., Wang J., Wang S., et al. Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma. Proteome Sci 2011, 9:21.
26. Zager R.A., Vijayan A., Johnson A.C. Proximal tubule haptoglobin gene activation is an integral component of the acute kidney injury "stress response". Am J Physiol Renal Physiol 2012, 303:F139-148.
27. Riaz S., Alam S.S., Srai S.K., Skinner V., Riaz A., Akhtar M.W. Proteomic identification of human urinary biomarkers in diabetes mellitus type 2. Diabetes Technol Ther 2010, 12:979-988.
28. Jiang H., Guan G., Zhang R., Liu G., Cheng J., Hou X., et al. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev 2009, 25:232-241.
29. Bhensdadia N.M., Hunt K.J., Lopes-Virella M.F., Michael Tucker J., Mataria M.R., Alge J.L., et al. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes. Kidney Int 2013, 83:1136-1143.
30. Cutillas P.R., Chalkley R.J., Hansen K.C., Cramer R., Norden A.G., Waterfield M.D., et al. The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am J Physiol Renal Physiol 2004, 287:F353-364.
31. Lemberger S.I., Dorsch R., Hauck S.M., Amann B., Hirmer S., Hartmann K., et al. Decrease of Trefoil factor 2 in cats with feline idiopathic cystitis. BJU Int 2011, 107:670-677.
32. Koonin E.V. Orthologs, paralogs, and evolutionary genomics. Annu Rev Genet 2005, 39:309-338.
33. Remm M., Storm C.E., Sonnhammer E.L. Automatic clustering of orthologs and in-paralogs from pairwise species comparisons. J Mol Biol 2001, 314:1041-1052.
34. Shaye D.D., Greenwald I. OrthoList: a compendium of C. elegans genes with human orthologs. PLoS One 2011, 6:e20085.
35. Nagaraj N., Mann M. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res 2011, 10:637-645.
36. Sun W., Chen Y., Li F., Zhang L., Yang R., Zhang Z., et al. Dynamic urinary proteomic analysis reveals stable proteins to be potential biomarkers. Proteomics Clin Appl 2009, 3:370-382.
37. Wisniewski J.R., Zougman A., Mann M. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J Proteome Res 2009, 8:5674-5678.
38. Stoop M.P., Singh V., Stingl C., Martin R., Khademi M., Olsson T., et al. Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patients. J Proteome Res 2013, 12:1101-1107.